Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-13 GILEAD SCIENCES, INC. 10% owner Purchase · Prefunded Warrants (right to buy) +3,739,000 $0.53 $2.0M 40,384,266
2025-11-26 GILEAD SCIENCES, INC. 10% owner Option exercise · Prefunded Warrants (right to buy) +13,335,000 $0.75 $10.0M 36,645,266
2025-11-26 GILEAD SCIENCES, INC. 10% owner Option exercise · Series B Warrants (right to buy) −13,335,000 0
2025-06-05 GILEAD SCIENCES, INC. 10% owner Purchase · Prefunded Warrants (right to buy) +13,335,000 23,310,266
2025-06-05 GILEAD SCIENCES, INC. 10% owner Purchase · Series A Warrants (right to buy) +13,335,000 13,335,000
2025-06-05 GILEAD SCIENCES, INC. 10% owner Purchase · Series B Warrants (right to buy) +13,335,000 13,335,000
2025-06-05 GILEAD SCIENCES, INC. 10% owner Purchase · Series C Warrants (right to buy) +13,335,000 13,335,000
2024-12-18 GILEAD SCIENCES, INC. 10% owner Purchase +1,759,978 $1.04 $1.8M 9,105,451
2024-12-18 GILEAD SCIENCES, INC. 10% owner Purchase · Prefunded Warrants (right to buy) +6,092,816 $1.04 $6.3M 9,975,266
2024-04-02 GILEAD SCIENCES, INC. 10% owner Purchase +485,250 $0.76 $369K 7,345,473
2024-04-02 GILEAD SCIENCES, INC. 10% owner Purchase · Prefunded Warrants (right to buy) +3,882,450 $0.76 $3.0M 3,882,450

Page 1 of 1 · 11 trades